公开(公告)号：US11678652B2

公开(公告)日：2023-06-20

申请号：US16602312

申请日：2017-12-27

申请人： Gordon Wayne Dyer

发明人： Gordon Wayne Dyer

IPC分类号： A01M1/20 ,  A01M1/22 ,  A01N53/00

CPC分类号： A01M1/2094 ,  A01M1/20 ,  A01M1/226 ,  A01N53/00 ,  A01M2200/011

摘要： The present invention is about turning the gaseous envelope that encoats, protects certain arthropods from their external environment against them. It teaches to apply radiation to the arthropods body in order to dysfunction the exacting geometry needed to maintain this protective envelope. This absorbed radiation thus makes the arthropod vulnerable to pesticides and other chemical agents. It also interferes with the arthropods ability to adequately breathe through their plastron covering by forcing it to increase its rate of metabolism via this absorbed radiation.

公开(公告)号：US11457626B2

公开(公告)日：2022-10-04

申请号：US15998259

申请日：2016-02-04

申请人： Gordon Wayne Dyer

发明人： Gordon Wayne Dyer

IPC分类号： A01N27/00 ,  A01N31/02 ,  A01N37/02 ,  A01N37/34 ,  A01N43/32 ,  A01N43/40 ,  A01N47/06 ,  A01N59/26 ,  A01N65/28

摘要： The present invention about using chemicals to interfere with the ability of certain arthropods to shield themselves from their external environment. It teaches to apply chemicals to a specialized portions of the arthropod's body that maintain a gaseous envelope that encoats, protects and extends from the arthropod's skin and, if present, breathing hole. This chemical application causes a failure of this protective envelope, making the arthropod vulnerable its external environment such as to pesticides and can also lead to problems with its ability to breathe.

公开(公告)号：US20140121645A1

公开(公告)日：2014-05-01

申请号：US13261795

申请日：2012-07-16

申请人： Gordon Wayne Dyer

发明人： Gordon Wayne Dyer

IPC分类号： A61M31/00 ,  A61M37/00

CPC分类号： A61M31/00 ,  A61K9/0043 ,  A61K9/0073 ,  A61M15/0098 ,  A61M16/0866 ,  A61M37/00 ,  A61M2202/0468 ,  A61M2210/0675

摘要： The present invention provides an indirect method and accompanying apparatus for supplying a high concentration of medicaments, particularly antibiotics, to the nasal sinuses by first loading the medicament into the cerebrospinal venous system (CVCS) via a Valsalva maneuver. Because the CVCS is a valveless, three-dimensional closed system, traditional physiological dogma such as veins always draining tissues does not always apply. Instead, because in its closed-system blood can flow in any direction, the blood of the CVCS and any medicaments that it contains will be drawn to any portion of it where there is increased outflow, such as the copious venousderived sinus fluid drainage present during nasal allergy or nasal infection. Thus, the very nasal congestion that impedes the effectiveness of direct medicament application, such as seen with nasal inhalers or systemic antibiotics, aids in applying the medicament indirectly to the nasal sinuses via the CVCS. Additionally, the present method has the benefit of delivering medicaments that, unlike present treatment regimens, are not limited solely to those medicaments that can be successfully absorbed from the G.I. tract. This means that, in the case of antibiotics, the bacteria infecting this portion of the CVCS will not be as resistant to treatment if they have not had prior exposure to this new line of antibiotics. Finally, if the infection extends to the eardrums, making the Valsalva maneuver painful, or if the patient is simply unusually sensitive, then earplugs to reduce the stress on the eardrums may be worn while the patient performs the Valsalva maneuver.

摘要翻译： 本发明提供了一种通过首先通过Valsalva操作将药物加载到脑脊静脉系统（CVCS）中来向鼻窦供应高浓度药物，特别是抗生素的间接方法和伴随装置。 因为CVCS是一种无阀式三维封闭系统，传统的生理教条如静脉总是排出组织并不总是适用。 相反，因为在其闭合系统的血液中可以流向任何方向，所以CVCS的血液及其含有的任何药物将被吸入其中增加流出物的任何部分，例如存在的大量静脉窦液体引流 鼻过敏或鼻感染。 因此，妨碍直接药物应用的有效性的鼻部充血，例如用鼻吸入器或全身抗生素观察，有助于通过CVCS间接地将药物施用于鼻窦。 此外，本方法具有递送药物的益处，其与现有的治疗方案不同，不仅仅限于可以从G.I.成功吸收的那些药物。 道。 这意味着，在抗生素的情况下，感染CVCS的这一部分的细菌如果没有接触过这种新的抗生素系列，就不会像治疗一样耐药。 最后，如果感染延伸到耳膜，使Valsalva手术变得痛苦，或者如果患者仅仅是异常敏感的话，那么当患者进行Valsalva手术时，可能会佩戴耳塞以减轻耳膜上的压力。

公开(公告)号：US20110301569A1

公开(公告)日：2011-12-08

申请号：US13199012

申请日：2011-08-16

申请人： Gordon Wayne Dyer

发明人： Gordon Wayne Dyer

IPC分类号： A61F11/00 ,  A61M37/00

CPC分类号： A61K9/0043 ,  A61K9/0073 ,  A61M15/0098 ,  A61M16/0866 ,  A61M2202/0468 ,  A61M2210/0675

摘要： The present invention provides an indirect method and accompanying apparatus for supplying a high concentration of medicaments, particularly antibiotics, to the nasal sinuses by first loading the medicament into the cerebrospinal venous system (CVCS) via a Valsalva manuever. Because the CVCS is a valveless, three-dimensional closed system, traditional physiological dogma such as veins always draining tissues does not always apply. Instead, because in its closed-system blood can flow in any direction, the blood of the CVCS and any medicaments that it contains will be drawn to any portion of it where there is increased outflow, such as the copious venous-derived sinus fluid drainage present during nasal allergy or nasal infection. Thus, the very nasal congestion that impedes the effectiveness of direct medicament application, such as seen with nasal inhalers or systemic antibiotics, aids in applying the medicament indirectly to the nasal sinuses via the CVCS. Additionally, the present method has the benefit of delivering medicaments that, unlike present treatment regimens, are not limited solely to those medicaments that can be successfully absorbed from the G.I. tract. This means that, in the case of antibiotics, the bacteria infecting this portion of the CVCS will not be as resistant to treatment if they have not had prior exposure to this new line of antibiotics. Finally, if the infection extends to the eardrums, making the Valsalva maneuver painful, or if the patient is simply unusually sensitive, then earplugs to reduce the stress on the eardrums may be worn while the patient performs the Valsalva maneuver.

摘要翻译： 本发明提供了一种通过首先通过Valsalva manuever将药物加载到脑脊静脉系统（CVCS）中来向鼻窦供应高浓度药物，特别是抗生素的间接方法和伴随装置。 因为CVCS是一种无阀式三维封闭系统，传统的生理教条如静脉总是排出组织并不总是适用。 相反，因为在其闭合系统的血液中可以流向任何方向，CVCS的血液及其含有的任何药物将被吸入其中流出物增加的任何部分，例如大量静脉导出的窦液引流 鼻过敏或鼻感染时出现。 因此，妨碍直接药物应用的有效性的鼻部充血，例如用鼻吸入器或全身抗生素观察，有助于通过CVCS间接地将药物施用于鼻窦。 此外，本方法具有递送药物的益处，其与现有的治疗方案不同，不仅仅限于可以从G.I.成功吸收的那些药物。 道。 这意味着，在抗生素的情况下，感染CVCS的这一部分的细菌如果没有接触过这种新的抗生素系列，就不会像治疗一样耐药。 最后，如果感染延伸到耳膜，使Valsalva手术变得痛苦，或者如果患者仅仅是异常敏感的话，那么当患者进行Valsalva手术时，可能会佩戴耳塞以减轻耳膜上的压力。

公开(公告)号：US06797104B1

公开(公告)日：2004-09-28

申请号：US09669831

申请日：2000-09-26

申请人： Gordon Wayne Dyer

发明人： Gordon Wayne Dyer

IPC分类号： B32B3128

CPC分类号： G02B1/14 ,  B29C65/1406 ,  B29C65/1416 ,  B29C65/1425 ,  B32B17/06 ,  B32B27/36 ,  B32B38/00 ,  B32B2307/40 ,  B32B2307/584 ,  B32B2309/68 ,  B32B2310/0862 ,  B32B2315/08 ,  B32B2398/00 ,  C03C2214/16 ,  C03C2214/20 ,  F41H5/0407 ,  G02B1/105 ,  Y10T428/24851 ,  Y10T428/24926

摘要： A method for making an optical composite composed of glass and plastic is disclosed. The method can be used to create a photochromic lens of high optical and refractive quality that is both scratch resistant and of high impact resistance. The method can also be used to create a strong sheath and/or cladding for an optic fiber. The method can also be used to create a scratch resistant coating for polycarbonate material, such as bulletproof glass. Vacuum pressure and optical contacting are used to hold the glass and plastic portions together. A flexible, peripheral seal, whose kinetic reaction strength has been enhanced with microwave radiation, is used maintain the vacuum adhesion of the glass and the plastic. This structural seal is located in a peripheral, non-optical portion of the optical composite to minimize any interference the seal may have with the optical function of the composite.

摘要翻译： 公开了一种制造由玻璃和塑料组成的光学复合材料的方法。 该方法可用于产生具有高耐光性和高耐冲击性的高光学和折射质量的光致变色镜片。 该方法还可以用于为光纤创建强护套和/或包层。 该方法也可用于制造用于聚碳酸酯材料的防刮涂层，例如防弹玻璃。 使用真空压力和光学接触将玻璃和塑料部分保持在一起。 使用微波辐射增强其动力学反应强度的柔性周边密封件可保持玻璃和塑料的真空附着力。 该结构密封件位于光学复合材料的外围非光学部分中，以最小化密封件与复合材料的光学功能可能具有的任何干扰。